trastuzumab emtansine
daiichi sankyo
['destiny,breast,2', 'breast', 'trastuzumab deruxtecan', 'destiny,breast,3', 'rux,(-crux),(-trux)']
following results of destiny-breast01 at the #asco23 #breastcancer oral session? icymi in by jerusalem et al: trastuzumab deruxtecan in #her2-positive metastatic #breastcancer patients with brain metastases: a destiny-breast01 subgroup analysis 
Executive Editor of Cancer Discovery @CD_AACR, published by @AACR. @BBS_Harvard/@DanaFarber alum. Native New Yorker. Views/likes/RTs are my own. She/her